A 36-Dimensional Cytometry by Time of Flight (CyTOF) Analysis of De NovoAcute Myeloid Leukemia (AML) Patients Eligible for Intensive Chemotherapy

MLA

Tislevoll, Benedicte Sjo, et al. “A 36-Dimensional Cytometry by Time of Flight (CyTOF) Analysis of De NovoAcute Myeloid Leukemia (AML) Patients Eligible for Intensive Chemotherapy.” Blood, vol. 132, no. 1, Number 1 Supplement 1, Nov. 2018, p. 1502. EBSCOhost, https://doi.org/10.1182/blood-2018-99-116943.

APA

Tislevoll, B. S., Fagerholt, O. H. E., Blaser, N., Hellesøy, M., Gullaksen, S.-E., Duran, P. A., Piechaczyk, L. I., Tadele, D., Skavland, J., Gavasso, S., Enserink, J., Fløisand, Y., & Gjertsen, B. (2018). A 36-Dimensional Cytometry by Time of Flight (CyTOF) Analysis of De NovoAcute Myeloid Leukemia (AML) Patients Eligible for Intensive Chemotherapy. Blood, 132(1, Number 1 Supplement 1), 1502. https://doi.org/10.1182/blood-2018-99-116943

Chicago

Tislevoll, Benedicte Sjo, Oda Helen Eck Fagerholt, Nello Blaser, Monica Hellesøy, Stein-Erik Gullaksen, Pilar Ayuda Duran, Laure Isabelle Piechaczyk, et al. 2018. “A 36-Dimensional Cytometry by Time of Flight (CyTOF) Analysis of De NovoAcute Myeloid Leukemia (AML) Patients Eligible for Intensive Chemotherapy.” Blood 132 (1, Number 1 Supplement 1): 1502. doi:10.1182/blood-2018-99-116943.